Donna Pasek - Amarin PLC Senior Resources
| AMRN Stock | USD 0.49 0.01 2.00% |
Executive
Donna Pasek is Senior Resources of Amarin PLC
| Address | Iconic Offices, The Greenway, Dublin, Ireland, 112-114 |
| Phone | 353 0 166 99020 |
| Web | https://www.amarincorp.com |
Amarin PLC Management Efficiency
The company has return on total asset (ROA) of (0.0345) % which means that it has lost $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0726) %, meaning that it created substantial loss on money invested by shareholders. Amarin PLC's management efficiency ratios could be used to measure how well Amarin PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.08. In addition to that, Return On Capital Employed is likely to drop to -0.12. At this time, Amarin PLC's Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ahmet Tezel | Johnson Johnson | N/A | |
| Elizabeth Forminard | Johnson Johnson | 53 | |
| John Tsai | Novartis AG ADR | 54 | |
| Johanna Mercier | Gilead Sciences | 54 | |
| Catherine Owen | Bristol Myers Squibb | 54 | |
| Alan Russell | Amgen Inc | N/A | |
| Adrian Kemp | AstraZeneca PLC ADR | N/A | |
| Elizabeth Shea | AbbVie Inc | N/A | |
| Shannon Klinger | Novartis AG ADR | 49 | |
| Sloan Simpson | Novartis AG ADR | N/A | |
| Elaine Chan | Scilex Holding | N/A | |
| Steven Baert | Novartis AG ADR | 45 | |
| Eric MD | Merck Company | 64 | |
| Madeleine Roach | Sanofi ADR | 40 | |
| FranoisXavier Roger | Sanofi ADR | 62 | |
| Flavius MD | Gilead Sciences | N/A | |
| Mark Larkins | Johnson Johnson | N/A | |
| Gideon Blumenthal | Merck Company | N/A | |
| Linda Higgins | Gilead Sciences | 62 | |
| Rudolf Ertl | Gilead Sciences | 78 | |
| William Winters | Novartis AG ADR | 60 | |
Management Performance
| Return On Equity | -0.0726 | ||||
| Return On Asset | -0.0345 |
Amarin PLC Leadership Team
Elected by the shareholders, the Amarin PLC's board of directors comprises two types of representatives: Amarin PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amarin. The board's role is to monitor Amarin PLC's management team and ensure that shareholders' interests are well served. Amarin PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amarin PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jason JD, Chief VP | ||
| Joseph JD, Exec Counsel | ||
| Jordan Zwick, Senior Relations | ||
| Alina Kolomeyer, Director Communications | ||
| Patrick Holt, CEO President | ||
| Nabil Abadir, Chief Affairs | ||
| Aaron Berg, Senior Vice President - Marketing and Sales | ||
| David Keenan, Executive Europe | ||
| Peter Fishman, Global VP | ||
| Jonathan Provoost, Executive Officer | ||
| Laurent Abuaf, President VP | ||
| Donna Pasek, Senior Resources | ||
| Karim Mikhail, CEO Pres | ||
| Thomas Reilly, Chief Officer | ||
| Steven Ketchum, President Officer | ||
| Lisa DeFrancesco, Sr Relations |
Amarin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amarin PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0726 | ||||
| Return On Asset | -0.0345 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | (0.59) % | ||||
| Current Valuation | (95.14 M) | ||||
| Shares Outstanding | 411.34 M | ||||
| Shares Owned By Insiders | 1.60 % | ||||
| Shares Owned By Institutions | 17.05 % | ||||
| Number Of Shares Shorted | 17.93 M | ||||
| Price To Earning | 590.00 X |
Pair Trading with Amarin PLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amarin PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will appreciate offsetting losses from the drop in the long position's value.Moving against Amarin Stock
| 0.69 | VTRS | Viatris | PairCorr |
| 0.68 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.64 | ESPR | Esperion Therapeutics | PairCorr |
| 0.51 | GILD | Gilead Sciences | PairCorr |
| 0.39 | EWTX | Edgewise Therapeutics | PairCorr |
The ability to find closely correlated positions to Amarin PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amarin PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amarin PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amarin PLC to buy it.
The correlation of Amarin PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amarin PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amarin PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amarin PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share (0.10) | Revenue Per Share 0.588 | Quarterly Revenue Growth (0.36) | Return On Assets (0.03) |
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.